Citation Impact
Citing Papers
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Molecular imaging in drug development
2008 Standout
Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors
1997
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
1991
Descending control of pain
2002 Standout
Glutamate uptake
2001 Standout
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity
1996
The precuneus: a review of its functional anatomy and behavioural correlates
2006 Standout
The 'atypicality' of antipsychotics: a concept re-examined and re-defined
2009 Nobel
Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study
1997
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide
1988 StandoutNobel
The adolescent brain and age-related behavioral manifestations
2000 Standout
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
1989
New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine
1995
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
A neuropsychological theory of positive affect and its influence on cognition.
1999 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
Neurotransmitters, receptors and neuropeptides in post‐mortem brains of chronic schizophrenic patients
1988
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Behavioral arrest: in search of the neural control system
2001
Genetic alteration of the α2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels
1999 StandoutNobel
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Neural Substrates of Spontaneous Musical Performance: An fMRI Study of Jazz Improvisation
2008 Standout
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
Neuroleptikabehandling vid schizofreni
1972
On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain
1975
Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine
1968
PHARMACOLOGICAL REGULATION OF CALMODULIN*
1980
Major psychosis and dopamine: controversial features and some suggestions
1984
A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine)
1982 StandoutNobel
Neuroleptic-Induced Decrease in Plasma Homovanillic Acid and Antipsychotic Activity in Schizophrenic Patients
1984 Science
Stress induced eating
1983
Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow
1973
A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain
1975
Second-sphere co-ordination of carboplatin and rhodium complexes by cyclodextrins (cyclomalto-oligosaccharides)
1989 StandoutNobel
The validity of animal models of depression
1984
Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat
1975
Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
1973
Separation of Metallocene Enantiomers by Liquid Chromatography: Chiral Recognition Via Cyclodextrin Bonded Phases
1985
Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity
1978
Morphine versus haloperidol catalepsy in the rat: A behavioral analysis of postural support mechanisms
1980
Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists
1976
Clozapine, Chlorpromazine, and Placebo in Newly Hospitalized, Acutely Schizophrenic Patients
1979
The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug
1975
A glutamatergic deficiency model of schizophrenia
1999 StandoutNobel
Influence of transient ischemia on monoamine metabolism in the rat brain during nitrous oxide and phenobarbitone anaesthesia
1978 StandoutNobel
Therapeutic effects of clozapine
1979
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine
1969 StandoutNobel
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells.
1994
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3, 4-dihydroxyphenylacetic acid (DOPAC) levels
1980
Dopamine and Schizophrenia: A Reappraisal in the Light of Clinical Studies with Clozapine
1977
Drugs, Neurotransmitters, and Schizophrenia
1974 Science
Trifluoperazine reduces inward ionic currents and secretion by separate mechanisms in bovine chromaffin cells.
1984 StandoutNobel
Multiple receptors for dopamine
1979 StandoutNature
Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
1975 Standout
About Sleep's Role in Memory
2013 Standout
Effects of clozapine on cerebral catecholaminergic neurone systems
1972
Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants
1984
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine
1969 StandoutNobel
Monoamine metabolism during bicuculline-induced epileptic seizures in the rat
1978 StandoutNobel
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
A psychomotor stimulant theory of addiction.
1987 Standout
Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain
1980
The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum
1975
Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: Studies with chronic clozapine and haloperidol
1982
Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines
1974
Chronic administration of haloperidol during development: Behavioral and psychopharmacological effects
1980
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
1980 Standout
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
THE INTERACTION OF NEUROLEPTIC AND MUSCARINIC AGENTS WITH CENTRAL DOPAMINERGIC SYSTEMS
1975
Antischizophrenic drugs: Affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects
1974
Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?
1973
Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
1983
Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons
1985
Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine
1981
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
1976 StandoutScience
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Blockade of p-chloromethamphetamine induced 5-hydroxytryptamine depletion by chlorimipramine, chlorpheniramine and meperidine
1971 StandoutNobel
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine
1982
Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotype
2011 StandoutNobel
1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues: A Promising Class of Monoamine Uptake Inhibitors
2006
Works of G Stille being referenced
The pharmacological properties of a potent neurotropic compound from the dibenzothiazepine group
1965
Kritische Stellungnahme zum Begriff der Neuroleptika
1971
The caudate spindle during various sleep stages
1972
[COMPARATIVE PHARMACOLOGICAL STUDY OF A NEW CENTRAL STIMULANT, 1-P-TOTYL-1-OXO-2-PYRROLIDINO-N-PENTANE HCL].
1963
6-(4-methyl-1-piperazinyl)morphanthridine (perlapine), a new tricyclic compound with sedative and sleep-promoting properties
1973
Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat
1974
Die Immobilisationsreaktion der Ratte als tierexperimentelles Modell für die Katatonie
1975
Observations concerning adrenergic functions and antidepressant activity: Pharmacological, biochemical and clinical results with a new imidazo-quinazoline derivative1
1968
[Pharmacological and neurochemical effects of clozapine (Leponex): new aspects in the drug therapy of schizophrenia].
1973
Demethylation of imipramine and antitetrabenazine effect in the catalepsy and ptosis test
1968
Effect of a striatal spreading depression on the pharmacogenic catatonia
1969
[Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
1969
Antipsychotics and antidepressants
1980
Neurophysiological substrates of the pharmacological criteria for neuroleptics.
1970
The neuroleptics. 3. Pharmacology. Introduction.
1970
Phase I metabolism of imipramine by foetal liver of man and rhesus monkey
1983
Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol
1973